Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Held by First Quadrant L P CA

First Quadrant L P CA held its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,200 shares of the medical equipment provider’s stock at the end of the second quarter. First Quadrant L P CA’s holdings in Intuitive Surgical were worth $2,993,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the stock. D. Scott Neal Inc. bought a new stake in shares of Intuitive Surgical during the second quarter worth $120,000. Guardian Life Insurance Co. of America raised its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the last quarter. Acropolis Investment Management LLC bought a new stake in shares of Intuitive Surgical during the first quarter worth $115,000. Parallel Advisors LLC raised its stake in shares of Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock worth $129,000 after buying an additional 14 shares during the last quarter. Finally, Huntington National Bank raised its stake in shares of Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock worth $130,000 after buying an additional 21 shares during the last quarter. Institutional investors own 97.56% of the company’s stock.

Intuitive Surgical, Inc. (NASDAQ ISRG) opened at 927.47 on Monday. Intuitive Surgical, Inc. has a 1-year low of $610.71 and a 1-year high of $974.66. The company’s 50 day moving average is $934.93 and its 200 day moving average is $803.42. The company has a market cap of $34.46 billion, a price-to-earnings ratio of 44.42 and a beta of 0.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The firm had revenue of $756.20 million for the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The firm’s revenue was up 12.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.62 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post $23.86 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by [[site]] and is the sole property of of [[site]]. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at [[permalink]].

A number of brokerages recently weighed in on ISRG. Royal Bank Of Canada lifted their price objective on shares of Intuitive Surgical from $800.00 to $950.00 and gave the company a “sector perform” rating in a report on Tuesday, July 18th. Canaccord Genuity reiterated a “hold” rating and set a $870.00 price objective on shares of Intuitive Surgical in a report on Tuesday, July 11th. Cantor Fitzgerald reiterated a “hold” rating and set a $1,050.00 price objective on shares of Intuitive Surgical in a report on Friday. Barclays PLC lifted their price objective on shares of Intuitive Surgical from $870.00 to $1,000.00 and gave the company an “overweight” rating in a report on Friday. They noted that the move was a valuation call. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and set a $1,050.00 price objective on shares of Intuitive Surgical in a report on Friday. Seven investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $953.97.

In other Intuitive Surgical news, CFO Marshall Mohr sold 8,950 shares of the firm’s stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $835.89, for a total transaction of $7,481,215.50. Following the sale, the chief financial officer now owns 6,422 shares of the company’s stock, valued at $5,368,085.58. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Jamie Samath sold 626 shares of the firm’s stock in a transaction that occurred on Tuesday, April 25th. The stock was sold at an average price of $825.00, for a total transaction of $516,450.00. Following the sale, the vice president now directly owns 94 shares in the company, valued at approximately $77,550. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,655 shares of company stock worth $23,366,682. 2.50% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).